Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Chiesi Farmaceutici

Chiesi Farmaceutici

Family-owned pharmaceutical company

Appears in 1 story

Stories

Chiesi acquires KalVista as pharma deepens rare disease push

Money Moves

Acquirer

For decades, people with hereditary angioedema had one option when an attack hit: inject themselves, often in a panic. In this genetic condition, the immune system misfires and swells tissues shut—sometimes fatally, closing the airway. In July 2025, a pill changed that.

Updated May 31